Genomics

Dataset Information

Deep minimal residual disease assessment redefines outcome and unveils different modes of treatment resistance in standard and high-risk multiple myeloma


ABSTRACT: Deep minimal residual disease assessment redefines outcome and unveils different modes of treatment resistance in standard and high-risk multiple myeloma

PROVIDER: PRJNA613235 | ENA |

REPOSITORIES: ENA